The general applications of PAC are: water treatment (potable process and waste water), gas and air purification, solvent recovery, decolourisation of sugar, vegetables oils and fats, deodorisation and purification of different products in the chemical (i.e. organic acids) or pharmaceutical (i.e. gastrointestinal capsule) or food industries (i.e. alcoholic and soft drinks).

The support, the scale and the inscriptions shall show no trace of distortion, discoloration or charring when maintained at 70 oC for 24 hours.

Prior to administration, the solution should be inspected visually for particulate matter and discoloration, and quality control should be performed (see section 12).

Uncommon: asthenia/ fatigue, injection-site haemorrhage, injection-site induration or warmth, injection-site mass, malaise. Rare: influenza-like illness, injection-site desquamation, injection-site discoloration, injection-site pruritus, injection-site rash non-specific, injection-site reaction, injection-site scar, hyperthermia, pain, pain/ tenderness/ soreness.

If so, after neutralization and decolorization in the laboratory, in accordance with the method set ou in Annex XIII to the aforementioned Regulation, they must have the following characteristics:

If so, after neutralization and decolorization in the laboratory, in accordance with the method set out in Annex XIII to the aforementioned Regulation, they must have the following characteristics:

Erythema nodosum, urticaria, angioedema, eczema, erythrosis, erythematous rash, pruritic rash, papular rash, hyperkeratosis, skin fissures, acne, dermatitis acneiforme, lichen sclerosus, decubitus ulcer, pigmentation lip, prurigo, rosacea, photosensitivity reaction, seborroeic dermatitis, skin burning sensation, skin desquamation, skin discolouration † †

Very rarely, liver damage and liver failure can occur. • Infections - you may experience chills, fever, flu syndrome, viral infections such as herpes simplex, inflammation of the throat (pharyngitis), inflammation of the mucous membranes of the nose (rhinitis) and fungal infection in the mouth (oral candidiasis). • Other disorders - swelling due to accumulation of fluid in body tissues (oedema), feeling and being sick (malaise), weakness (asthenia), pain (especially back pain and chest pain). • Irritation around the injection site - swelling, redness, soreness and discoloured skin.

Uncommon side effects (affects less than 1 in 100): • Swelling due to water retention in the body • High levels of fats in the blood (such as cholesterol or triglycerides) • Uncontrollable emotions • Anxiety • Problems sleeping (insomnia) • Less interest in sex • Skin rash, redness of the skin • Swelling of the breasts, lumps in the breast or abnormal breast milk production • Premenstrual syndrome • Vaginal bleeding or dryness • Problems where the patch has been on the skin (such as swelling, discoloured skin, pain, spots, blisters or the skin feeling over-sensitive) • Swelling • Rise in blood pressure.

Uncommon side effects, (may occur in fewer than 1 in 100, but more than 1 in 1,000 patients): A feeling of weakness or feeling unwell, high blood pressure, chills or fever, heartburn, anorexia, constipation, bruising, localised swelling with fluid (oedema), weight loss, muscle aches, painful joints, back pain, reduced feeling or tingling in toes or fingers, sleeplessness, depression, confusion, nervousness, dry mouth, loss of memory, allergic coughing, breathlessness, nosebleed, lung infection, hair loss, skin itching or discolouration, impotence.

The permanganate clearing time, as determined by the method specified, is the number of minutes required for the colour of the sample to match that of the colour standard after adding 1 ml of a 1 mmol/l potassium permanganate solution to 10 ml of the sample.

reactions (incl. erythema, pruritus, irritation, rash, dermatitis, vesicles, pain, eczema, inflammation, swelling, discolouration, papules, excoriation, urticaria, hypersensitivity) Fatigue

Other less common and usually mild side-effects which may affect between 1 and 10 people in 100 have been seen: decreases in the number of white blood cells or red blood cells, skin rashes, slight hair loss, weariness, fever, weakness, drowsiness, headache, numbness or tingling sensations, taste changes, dizziness, sleeplessness, swelling in the legs, constipation, dehydration, cold sores, inflammation of the nose and throat, chest infection, depression, problems with the eyes, inflammation of the veins (thrombophlebitis), shortness of breath, nose bleeds, cough, runny nose, bleeding from the gut, heartburn, excess wind, dry mouth, skin discolouration, nail disorder, pain in the joints, chest or back and loss of weight.

Other less common and usually mild side-effects which may affect between 1 person and 10 people in 100 have been seen: decreases in the number of white blood cells or red blood cells, skin rashes, slight hair loss, weariness, fever, weakness, drowsiness, headache, numbness or tingling sensations, taste changes, dizziness, sleeplessness, swelling in the legs, constipation, dehydration, cold sores, inflammation of the nose and throat, chest infection, depression, problems with the eyes, inflammation of the veins (thrombophlebitis), shortness of breath, nose bleeds, cough, runny nose, bleeding from the gut, heartburn, excess wind, dry mouth, skin discolouration, nail disorder, pain in the joints, chest or back and loss of weight.

UN/ECE standard FFV-14 does not include any provision with regard to degreening procedures authorised by Member States, procedures that are covered by the provisions of Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant-protection products on the market(3).

The most common side effects in patients receiving Avastin with or without chemotherapy (seen in more than 1 patient in 10) are leucopenia (low levels of leucocytes, a type of white blood cell), thrombocytopenia (low levels of platelets in the blood), neutropenia (low levels of neutrophils, a type of white blood cell), peripheral sensory neuropathy (damage to nerves in the extremities, such as the hands and feet), hypertension (high blood pressure), diarrhoea, nausea (feeling sick), vomiting, asthenia (weakness), fatigue (tiredness), anorexia (loss of appetite), dysgeusia (taste disturbances), headache, eye disorders, dyspnoea (difficulty breathing), epistaxis (nosebleeds), rhinitis (blocked nose), constipation, stomatitis (inflammation of the lining of the mouth), rectal haemorrhage (bleeding from the rectum), exfoliative dermatitis (flaky skin), dry skin, skin discoloration, proteinuria (protein in the urine), pyrexia (fever) and pain.

In clinical studies, the most common side effects with Sutent (seen in more than 1 patient in 10) were anaemia (low red blood cell counts), neutropenia (low white blood cell counts), thrombocytopenia (low blood platelet counts), hypothyroidism (underactive thyroid gland), decreased appetite, taste disturbance, headache, hypertension (high blood pressure), epistaxis (nosebleeds), diarrhoea, nausea (feeling sick), vomiting, stomatitis (inflammation of the lining of the mouth), dyspepsia (heartburn), abdominal (tummy) pain or distension (bloating), constipation, glossodynia (burning or tingling sensation around the mouth), flatulence (gas), oral (mouth) pain, dry mouth, yellow skin or skin discoloration, palmar-plantar erythrodysaesthesia syndrome (swelling and numbness of the palms and soles of the feet), hair colour changes, rash, dry skin, alopecia (hair loss), pain in the extremities (hands and feet) or limbs, fatigue or asthenia (tiredness or weakness), mucosal inflammation (inflammation of the moist body surfaces), oedema (swelling) decreased ejection fraction (reduced amount of blood pumped out in each heartbeat) and decreased weight.

when the euro banknotes have been discoloured by activated anti-theft devices and they are presented by professional banknote handlers as referred to in Article 6(1) of Council Regulation (EC) No 1338/2001 of 28 June 2001 laying down measures necessary for the protection of the euro against counterfeiting(4): a written statement on the cause and the nature of neutralisation shall be provided by the professional banknote handlers;

You should consult your doctor if you experience any of these: • Swelling of lymph nodes • Increased body hair, diabetes, gout, increased appetite, changes to blood chemistry including reduced blood protein (including the proteins that fight infection) and changes to blood phosphate, blood sodium, thyroid hormone and the hormone that controls salt and water absorption, thirst • Changes to mental status or personality, abnormal dreams, loss of libido, panic attack, restlessness, • Voice disorder or voice loss, impaired concentration, impaired balance, movement difficulty, loss of sense of smell • Loss of vision, swelling of eyelid, eye irritation and redness, dry eye, discharge from eye • Deafness, ear pain or itching, ringing in the ear • Collapse, circulatory problems, fast, slow or irregular heart beat, shortness of breath especially when lying down (which may be a symptoms of heart failure) • Wheezing, increased throat secretions, dry throat, nasal or sinus congestion or pain, laryngitis • Rapid swelling of the skin, especially on back of hands or feet, or of eyelids, lips, face, tongue or genitals • Bleeding from bowels, stomach or gums, difficulty or pain on swallowing, haemorrhoids, inflammation, pain or ulceration of mouth, tongue or lips, toothache and coated tongue • Yellowing of the skin (due to alteration in the function of the liver) • Skin eruptions, skin cracking, flaking or discoloration, pressure sores, acne, sensitivity to sunlight • Difficulty passing urine, passing urine more frequently • Certain types of tumour of skin and brain.

110 Uncommon (affects 1 to 10 users in 1000): • Excessive drinking of water, stool incontinence, thirsty, very hard faeces, hoarseness or voice disorder • Lung infection caused by inhaling of food into the breathing passages, bladder infection, ‘ pink eye’, sinus infection, viral infection, ear infection, tonsil infection, infection under the skin, eye infection, stomach infection, eye discharge, yeast infection of nails • Abnormal electrical conduction of the heart, drop in blood pressure after standing, low blood pressure, feeling dizzy after changing body position, abnormal electric activity tracing of the heart (ECG), abnormal heart rhythm, awareness of heart beating, heart rate increased or decreased • Urinary incontinence, pain when passing urine, frequent passing of urine • Confused, disturbance in attention, low level of consciousness, excessive sleep, nervousness, elated mood (mania), lack of energy and interest • Blood sugar increased, liver enzymes increased, white blood cell count decreased, low haemoglobin or red blood cell count (anaemia), increase in eosinophils (special white blood cells), blood creatinine phosphokinase increased, decrease in platelets (blood cells that help you stop bleeding) • Muscle weakness, muscle pain, ear pain, neck pain, joint swelling, abnormal posture, joint stiffness, musculoskeletal chest pain, chest discomfort • Skin lesion, skin disorder, dry skin, intense itching of skin, acne, hair loss, skin inflammation caused by mites, skin discoloration, thickening of skin, flushing, reduced skin sensitivity to pain or touch, inflammation of oily skin • No menstruation, sexual dysfunction, erectile dysfunction, ejaculation disorder, breast discharge, enlargement of breast in men, decreased sexual drive, irregular menstruation, vaginal discharge • Fainting, gait disturbance, sluggishness, decreased appetite resulting in malnutrition and low body weight, feeling ‘ out of sorts’, balance disorder, allergy, edema, speech disorder, chills, abnormal coordination • Painful oversensitivity to light, increased blood flow to the eye, eye swelling, dry eye, increase in tears • Breathing passage disorder, lung congestion, crackly lung noise, congestion of breathing passages, trouble speaking, difficulty swallowing, cough with sputum, coarse/ whistling sound during breathing, flu-like illness, sinus congestion • Unresponsive to stimuli, loss of consciousness, sudden swelling of lips and eyes along with difficulty breathing, sudden weakness or numbness of the face, arms, or legs, especially on one side, or instances of slurred speech that last for less than 24 hours (these are called mini-strokes or strokes), involuntary movements of face, arms, or legs, ringing in ears, face edema.

29 Immune System Disorders Drug hypersensitivity Metabolism and Nutrition Disorders Anorexia, Polydipsia Psychiatric Disorders Confusional state, Listless, Anorgasmia, Blunted affect Nervous System Disorders Unresponsive to stimuli, Loss of consciousness, Neuroleptic malignant syndrome, Diabetic coma, Cerebrovascular accident, Depressed level of consciousness, Cerebral ischemia, Cerebrovascular disorder, Transient ischemic attack, Dysarthria, Disturbance in attention, Balance disorder, Speech disorder, Coordination abnormal, Movement disorder Eye Disorders Ocular hyperemia, Eye discharge, Eye swelling, Dry eye, Lacrimation increased, Photophobia, Visual acuity reduced, Eye rolling, Glaucoma Ear and Labyrinth Disorders Tinnitus Vascular Disorders Flushing Respiratory, Thoracic, and Mediastinal Disorders Wheezing, Pneumonia aspiration, Pulmonary congestion, Respiratory disorder, Rales, Epistaxis, Respiratory tract congestion, Hyperventilation, Dysphonia Gastrointestinal Disorders Dysphagia, Faecal incontinence, Faecaloma, Lip swelling, Cheilitis Skin and Subcutaneous Tissue Disorders Skin lesion, Skin disorder, Skin discoloration, Seborrheic dermatitis, Hyperkeratosis, Dandruff, Erythema Musculoskeletal, Connective Tissue, and Bone Disorders Rhabdomyolysis, Joint swelling, Posture abnormal, Joint stiffness Renal and Urinary Disorders Enuresis, Dysuria, Pollakiuria Reproductive System and Breast Disorders Ejaculation disorder, Vaginal discharge, Menstrual disorder General Disorders and Administration Site Conditions Generalised oedema, Face oedema, Gait disturbance, Thirst, Chills, Peripheral coldness, Drug withdrawal syndrome

possible effects on amenities (e.g. floating or stranded material, turbidity, objectionable odour, discolouration and foaming);

additionally, the effluent shall not produce visible floating solids in, nor cause discolouration of the surrounding water; or